Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1051 | 677 | 0.0634 | 0.0618 | 0.6441 | 0.6473 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1420 | 605 | 0.1381 | 0.1369 | 0.4261 | 0.4519 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1359 | 632 | 0.1232 | 0.1369 | 0.4650 | 0.4519 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 1647 | 765 | 0.1494 | 0.1369 | 0.4645 | 0.4519 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 703 | 475 | 0.0386 | 0.0355 | 0.6757 | 0.7189 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 622 | 430 | 0.0325 | 0.0355 | 0.6913 | 0.7189 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 989 | 781 | 0.0352 | 0.0355 | 0.7897 | 0.7189 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1107 | 1003 | 0.0176 | 0.0199 | 0.9061 | 0.8770 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1013 | 887 | 0.0213 | 0.0199 | 0.8756 | 0.8770 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 810 | 688 | 0.0207 | 0.0199 | 0.8494 | 0.8770 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 917 | 823 | 0.0159 | 0.0171 | 0.8975 | 0.8905 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1025 | 921 | 0.0176 | 0.0171 | 0.8985 | 0.8905 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 835 | 731 | 0.0176 | 0.0171 | 0.8754 | 0.8905 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1155 | 902 | 0.0429 | 0.0307 | 0.7810 | 0.8523 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1110 | 992 | 0.0200 | 0.0307 | 0.8937 | 0.8523 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1459 | 1287 | 0.0291 | 0.0307 | 0.8821 | 0.8523 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 694 | 626 | 0.0115 | 0.0093 | 0.9020 | 0.9244 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 736 | 681 | 0.0093 | 0.0093 | 0.9253 | 0.9244 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 759 | 718 | 0.0069 | 0.0093 | 0.9460 | 0.9244 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1539 | 1471 | 0.0115 | 0.0099 | 0.9558 | 0.9514 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1142 | 1078 | 0.0108 | 0.0099 | 0.9440 | 0.9514 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 963 | 919 | 0.0075 | 0.0099 | 0.9543 | 0.9514 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 661 | 623 | 0.0064 | 0.0054 | 0.9425 | 0.9547 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 726 | 696 | 0.0051 | 0.0054 | 0.9587 | 0.9547 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 752 | 724 | 0.0047 | 0.0054 | 0.9628 | 0.9547 |